Table 3 Evidence of routine WBCT versus non-routine WCBT
From: Structured approach with primary and secondary survey for major trauma care: an overview of reviews
COMPARISON routine WBCT vs non-routine WBCT | Overlapping CCA | Certainty of evidence (GRADE) | Update search strategy | Overall effects | Total participants | Concordance/Discordance |
|---|---|---|---|---|---|---|
Overall mortality | Â | Â | Â | Â | Â | Â |
Chidambaram (2017) | 33.33% | LOW | September 2016 | OR 0.74 (0.61,0.91) | 32,207 | Favour routine WBCT |
Hajibandeh (2015) | LOW | October 2013 | OR 0.69 (0.56,0.84) | 34,468 | Favour routine WBCT | |
Arruzza (2020) | LOW | December 2019 | OR 0.85 (0.71,1.02) | 63,539 | No difference | |
Sierink (2012) | MODERATE | November 2010 | OR 0.91 (0.79,1.05) | 5309 | No difference | |
Caputo (2013) | LOW | 2013 | OR 0.75 (0.7,0.79) | 25,782 | Favour routine WBCT | |
Jiang (2013) | LOW | December 2013 | OR 0.66 (0.52,0.85) | 26,065 | Favour routine WBCT | |
Healy (2013) | LOW | October 2012 | OR 0.68 (0.43,1.09) | 8180 | No difference | |
24-h mortality | Â | Â | Â | Â | Â | Â |
Chidambaram (2017) | 42.86% | LOW | September 2016 | OR 0.72 (0.66,0.79) | 20,206 | Favour routine WBCT |
Arruzza (2020) | MODERATE | Â | OR 0.86 (0.65,1.21) | 20,374 | No difference | |
ICU LOS | Â | Â | Â | Â | Â | Â |
Chidambaram (2017) | 27.78% | LOW | September 2016 | MD 1.97 (1.59, 2.34)Â | 22,631 | Favour non-routine WBCT |
Arruzza (2020) | LOW | December 2019 | SMD 0.08 (− 0.13,0.29) | 18,645 | No difference | |
Jiang (2013) | LOW | December 2013 | MD 0.95 (− 0.08,1.98) | 18,755 | No difference | |
Complication (MODS/MOF) | Â | Â | Â | Â | Â | Â |
Arruzza (2020) | 50% | LOW | December 2019 | OR 1.88 (0.61,5.83) | 18,010 | No difference |
Jiang (2013) | LOW | December 2013 | OR 2.50 (0.82,7.65) | 17,763 | No difference | |
Radiation dose | Â | Â | Â | Â | Â | Â |
Arruzza (2020) | NA | MODERATE | December 2019 | No meta-analysis: all 4 included studies reported p < 0.001 | 3029 | Favour non-routine WBCT |
Hospital LOS | Â | Â | Â | Â | Â | Â |
Chidambaram (2017) | 20.83% | MODERATE | September 2016 | MD1.03 (0.25,1.81) | 21,710 | Favour non-routine WBCT |
Sierink (2012) | MODERATE | November 2010 | MD 0.57 (− 5.84, 6.98) | 4991 | No difference | |
Arruzza (2020) | LOW | December 2019 | SMD 0.08 (− 0.18, 0.34) | 18,528 | No difference | |
Jiang (2013) | MODERATE | December 2013 | MD 0.56 (− 0.03, 1.15) | 17,393 | No difference | |
Time spent in ER | Â | Â | Â | Â | Â | Â |
Chidambaram (2017) | 25% | LOW | September 2016 | MD − 14.18 (− 17.02,− 12.60) | 5912 | Favour routine WBCT |
Sierink (2012) | NA | November 2010 | No meta-analysis |  | – | |
Time spent in ED | Â | Â | Â | Â | Â | Â |
Arruzza (2020) | 27.78% | LOW | December 2019 | SMD − 0.70 (− 1.19, − 0.22) | 18,789 | Favour routine WBCT |
Healy (2013) | LOW | October 2012 | SMD − 32.39 (− 51.78, − 13.00) | 6073 | Favour routine WBCT | |
Jiang (2013) | LOW | December 2013 | SMD − 25.58 (− 43.04, − 12.12) | 18,294 | Favour routine WBCT |